Hillevax

Hillevax Liabilities

Delisted

The The Liabilities of Hillevax (HLVX) as of Nov 20, 2026 is 38.20 M USD. In the previous year, The Liabilities was 78.91 M USD — a change of -51.58% (lower).

Liabilities

38.20 MUSD

YoY

-51.58%

Last updated:

In 2024, Hillevax's total liabilities amounted to 38.20 M USD, a -51.58% difference from the 78.91 M USD total liabilities in the previous year.

The Hillevax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
1.12 M USD
Jan 1, 2020
3.28 M USD
Jan 1, 2021
227.92 M USD
Jan 1, 2022
49.98 M USD
Jan 1, 2023
78.91 M USD
Jan 1, 2024
38.20 M USD
The Hillevax Liabilities history
YEARLiabilitiesYoY
38.20 MUSD-51.58%
78.91 MUSD+57.87%
49.98 MUSD-78.07%
227.92 MUSD+6,852.90%
3.28 MUSD+192.16%
1.12 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Hillevax's Liabilities

Hillevax's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Hillevax's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Hillevax's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Hillevax's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Hillevax’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Hillevax stock

The Liabilities of Hillevax is 38.20 M USD in 2024.

The Liabilities of Hillevax changed from 78.91 M USD to 38.20 M USD, representing a -51.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Hillevax since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Hillevax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Hillevax

All Key Metrics — Hillevax